» Articles » PMID: 1103722

[Comparative Clinical Pharmacology of Gentamicin, Sisomicin, and Tobramycin]

Overview
Specialty Pharmacology
Date 1975 Oct 1
PMID 1103722
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Using a randomized crossover design involving 12 normal subjects, we studied comparatively the pharmacokinetics and tolerance of three aminoglycoside antibiotics, gentamicin, sisomicin, and tobramycin. Serum concentrations were determined during 8 h and the urine recovery rate was determined within 24 h after a 1-h intravenous infusion of the respective antibiotic in a dose of 1 mg/kg of body weight. Microbiological assay was performed with the agar diffusion test (Bacillus subtilis); pharmacokinetic calculations were performed by means of a digital computer on the basis of a mathematical model of an open, two-compartment system. Of the three antibiotics studied, gentamicin showed the lowest concentration in serum after termination of the 1-h infusion (3.85 +/- 0.67 mug/ml), and the serum-regression curve steadily lay below those of the two other antibiotics. Sisomicin had the highest serum concentrations (4,66 +/- 1.24 mug/ml) and the serum-level curve exceeded that of the two other antibiotics. Tobramycin occupied a position between sisomicin and gentamicin in form of its serum level characteristics. Corresponding to the serum kinetics we also found slight differences in the pharmacokinetic parameters, especially in serum half-lives, elimination constants, and areas under the serum level curves. The test of liver and kidney functions and the hematological systems, as well as the function of the stato-acusticus nerve, showed no pathological changes by any of the three antibiotics tested.

Citing Articles

Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.

Jiao Y, Moya B, Chen M, Zavascki A, Tsai H, Tao X Antimicrob Agents Chemother. 2019; 63(7).

PMID: 30988147 PMC: 6591590. DOI: 10.1128/AAC.00425-19.


Ocular pharmacokinetics of tobramycin. A comparative radioimmunoassay and microbiological assay.

Desai S Int Ophthalmol. 1993; 17(4):201-10.

PMID: 8112967 DOI: 10.1007/BF01007741.


Comparison of netilmicin and gentamicin pharmacokinetics in humans.

Chung M, Costello R, SYMCHOWICZ S Antimicrob Agents Chemother. 1980; 17(2):184-7.

PMID: 7387140 PMC: 283755. DOI: 10.1128/AAC.17.2.184.


Pharmacokinetic study of sisomicin in humans.

Chung M, Schrogie J, SYMCHOWICZ S J Pharmacokinet Biopharm. 1981; 9(5):535-51.

PMID: 7334458 DOI: 10.1007/BF01061025.


Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.

Goto M, Sugiyama M, Ishizaki T Antimicrob Agents Chemother. 1980; 18(3):372-6.

PMID: 6775594 PMC: 284008. DOI: 10.1128/AAC.18.3.372.


References
1.
JAO R, JACKSON G . GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION. JAMA. 1964; 189:817-22. DOI: 10.1001/jama.1964.03070110019004. View

2.
RIFF L, JACKSON G . Pharmacology of gentamicin in man. J Infect Dis. 1971; 124 Suppl:S98-105. DOI: 10.1093/infdis/124.supplement_1.s98. View

3.
STRATFORD B, DIXSON S, Cobcroft A . Serum levels of gentamicin and tobramycin after slow intravenous bolus injection. Lancet. 1974; 1(7854):378-9. DOI: 10.1016/s0140-6736(74)93148-1. View

4.
Naber K, Westenfelder S, Madsen P . Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother. 1973; 3(4):469-73. PMC: 444436. DOI: 10.1128/AAC.3.4.469. View

5.
Simon V, Mosinger E, Malerczy V . Pharmacokinetic studies of tobramycin and gentamicin. Antimicrob Agents Chemother. 1973; 3(4):445-50. PMC: 444432. DOI: 10.1128/AAC.3.4.445. View